Literature DB >> 18835528

Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation.

Gregory W Fischer1, Ylva Bengtsson, Suzanne Scarola, Edmond Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835528     DOI: 10.1053/j.jvca.2008.07.015

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  6 in total

1.  Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation.

Authors:  S Sandy An; C Patrick Henson; Robert E Freundlich; Matthew D McEvoy
Journal:  Am J Transplant       Date:  2018-04-02       Impact factor: 8.086

2.  Vasopressin deficiency and vasodilatory state in end-stage liver disease.

Authors:  Gebhard Wagener; Galina Kovalevskaya; Moury Minhaz; Fallon Mattis; Jean C Emond; Donald W Landry
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-12-03       Impact factor: 2.628

3.  Acute heart failure after Orthotopic liver transplantation: a case series from one center.

Authors:  Sonal Sharma; Kunal Karamchandani; Ryan Wilson; Sean Baskin; Dmitri Bezinover
Journal:  BMC Anesthesiol       Date:  2018-07-31       Impact factor: 2.217

4.  The Use of Methylene Blue during Liver Transplantation for Vasoplegia.

Authors:  Paul Harding; Thomas Nicholas; Cale Kassel
Journal:  Case Rep Anesthesiol       Date:  2021-06-23

5.  Use of methylene blue for treatment of severe sepsis in an immunosuppressed patient after liver transplantation.

Authors:  Saravanan Ramamoorthy; Shachi Patel; Eric Bradburn; Zakiyah Kadry; Tadahiro Uemura; Piotr K Janicki; Riaz Ali Shah; Dmitri Bezinover
Journal:  Case Rep Transplant       Date:  2013-05-13

Review 6.  Postreperfusion syndrome during liver transplantation.

Authors:  Sung-Moon Jeong
Journal:  Korean J Anesthesiol       Date:  2015-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.